Ejemplo: Heart Attack

Ensayos clínicos patrocinados por Favrille

Total 6 resultados

NCT00041730

Estado desconocido

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

Condiciones: Non-Hodgkin's Lymphoma
NCT00036426

Estado desconocido

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Condiciones: Lymphoma, Low-Grade
NCT00324831

Suspendido

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Condiciones: Lymphoma
NCT00258336

Estado desconocido

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

Condiciones: Lymphoma
NCT00104819

Terminado

Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma

Condiciones: Lymphoma
NCT00089115

Terminado

Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Condiciones: Lymphoma